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Dear Editor, 
Beta Thalassemia major is a genetic disease with an 
autosomal recessive pattern and is differentiated by 
severe  microcytic  hypochromic  hemolytic  anemia 
with  hepatosplenomegaly,  ineffective  erythropoiesis 
and  bone  marrow  expansion.
1  The  β-globin  (HBB) 
gene coding for β-chain expression is located on a 50 
kb globin gene cluster on the short arm of chromo-
some  11,  whose  mutation  mediated  inactivation  is 
usually responsive for the outcome of disease. Beta 
thalassemia occurs frequently in the coastline areas of 
the world. The Iran, with approximately 25000 beta 
thalassemia major patients and two millions expected 
carriers  and  an  overall  carrier  frequency  of  4-8%, 
counts to the Middle East countries with the highest 
prevalence of beta thalassemia.
2 The Khuzestan Prov-
ince  in  the  southwest  Iran  with  approximately 
4.000.000 inhabitants  ranks  to  the  regions  with  the 
higher prevalence of the beta thalassemia, the most 
common type of hemoglobinopathies in Iran.
3 More-
over, the cities Eizeh with nearly 120.000 and Baq-
Malek with 25.000 citizens are located in the North 
Khuzestan and are categorized to the small cities with 
relatively high carriers of the beta thalassemia.  
In  the  last  decade,  numerous  studies  have  been 
published about distribution and frequency of muta-
tions  within  the  HBB  gene  in  some  regions  of  the 
Iran.
4,5 These data were used to manage and provide a 
country-wide network for detecting beta thalassemia 
carrier and major individuals, which need intensive 
medical care. Nowadays, there are centers with spe-
cial task to perform prenatal molecular diagnosis of 
the beta thalassemia in Iran with the goal to radically 
reduce  the  transfusion  dependent  beta  thalassemia 
patients. However, the success of such centers is de-
pending on the expanding knowledge about the kind 
and the continuation of pathogenic mutations within 
the ethnic groups in different area of the country.
6 
We firstly attempted also to fully analyze the beta 
globin gene in 130 blood transfusion dependent indi-
viduals  in  the  two  closely  located  towns,  namely 
Eizeh and Baq-malek, After investigation a cohort of 
200  beta  thalassemia  major  patients  and  more  than 
1000 carriers in the Khuzestan Province in a previous 
study,
3  where  we  showed  more  than  40  mutations 
within different ethnic groups in the province. Cur-
rently,  we  would  know,  whether  the  pure  ethnic 
group  such  as  Bakhtiari  suggests  similar  frequency 
and distribution of mutations in the HBB gene as the 
province-wide study indicated.  
A total of 260 beta-globin alleles resulting from 
130  blood  transfusion-dependent  patients  (beta  tha-
lassemia  major)  were  studied.  All  of  analyzed  pa-
tients  belonged  to  the  Bakhtiari  ethnicity.  Full  se-
quencing of the beta globin gene in the subjected in-
dividuals  revealed  15  β-thalassemia  causing  muta-
tions as have been listed in the Table1. Fifty eight 
patients were homozygous and 72 patients were com-
pound  heterozygous  for  mutations. The seven  most 
frequent  mutations  constituted  83.92%  of  all  muta-
tions. The mutations CD36/37(-T) and the  IVS-II-1 
were with 22.70% and 19.23% the most common mu-
tations, accordinely.  
In addition, we found in 11.53% of cases (No=30), 
the mutation 5UTR+20 in association with the IVSII-
745 on one allele ( in cis) either compound with the 
3
th  mutation  on  the  second  allele  (N=12)  or  in 
hemozygous  manner  (in  9  cases;  N=18).  The  beta 
thalassemia major individuals were also subjected for 
screening of the HBB gene in the two neighboring 
cities in the north-east Khuzestan Province because of Rare mutations in beta globin gene 
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some  reasons;  both  cities  harbor  the  ethnic  group 
“Bakhtiari” with less than 300.000 inhabitants, which 
show relatively high prevalence of beta thalassemia 
carriers.
5 Comparative studies were performed from 
different provinces in the Iran,
1-5 but just few investi-
gations were particularly based on the ethnic groups 
(e.g. Arab, Tork, Lor, etc.).   
In general, a minor part of thalassemia mutations 
predominant  for  geographic  regions  or  countries.
6-8 
We showed in a previous province-wide study more 
than 40 mutations and in the present study 14 differ-
ent mutations with similar trends regarding the distri-
bution and the frequency. In contrast, we did find a 
mutation at 5
/UTR (+20) with more than 11%, which 
was reported in the province and in the country-wide 
study with 1% as a rarely event.
3 According to the 
previous reports, the mentioned mutation occur usual-
ly in cis with the mutation IVSII-745(C>G) and the 
most  prevalence  of  the  mentioned  mutation  was 
reported in Turkish Cypriots with 6.07% and in Sicilian 
with 6.16%.
9,10 We propose it therefore for founder muta-
tion, at least in Iran, because of its rare detection rate in 
other regions of the country. Nevertheless, the hypothesis 
of founder effect has to be proven by genealogical studies 
in the target population. Such studies about carrier fre-
quency and origin of mutations in the specific regions 
would be beneficial to better understand the rout and ex-
pansion of pathogenic mutations in the HBB gene. 
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Table 1: Frequency of detected mutations in the ethnic group from Eizeh and Baq-Malek in comparison to other 
provinces in Iran. 
Mutations  Type  N 
(allele) 
Eizeh & Baq-
Malek (in %) 
Khuzesta
n (in %) 
Mazandaran  
& Gilan (in %) 
Origin 
CD36/37 -T  β
0  59  22.70  20.54  0.8  Kurdish .Iranian 
IVSII-1(G>A)  β
0  50  19.23  20.01  56.1  Mediterranean, US Blacks 
5
/UTR +20(C>T)
a   β
+  30  11.53  1.00  -   Iranian 
BETA -28 (A>C)  β
+  27  10.38  2.10  0.5   Kurdish 
IVSI-110(G->A)  β
+  22  8.46  14.18  2.5   Mediterranean 
CD8 (-AA)  β
0  16  6.15  3.00  1.5   Mediterranean 
BETA -88(C>A)  β
+  15  5.77  0.82  0.3   Kurdish 
IVSI(-del 25nt)  β
0  8  3.06  2.54  1.2   Med East 
IVSII-745[C>G] 
a  β
+  30  11.53  1.30  2.3   Mediterranean 
CD44 (-C)  β
0  6  2.30  1.73  -   Kurdish 
IVSI-1 (G>A)  β
0  5  1.92  3.73  0.8   Mediterranean 
CD22/23/24 (-
AAGTTGG) 
β
0  5  1.92  0.64  3.0   Turkish 
INITIATION CO-
DON[T>C] 
β
0  5  1.92  0.36  -   East Asia .Med 
IVSI-5(G->C)  β
+  4  1.54  5.18  2.3   Asian Indian, SE Asian, 
Melanesian 
CD39 (C>T)  β
0  4  1.54  3.50  -   Mediterranean 
CD5 (-CT)  β
0  4  1.54  4.63  0.5  Mediterranean 
TOTAL  -  260  100  -  -  - 
a both mutations occurred always in cis. 
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